Breakout Sessions : Power of AI/ML in Biopharma Drug Discovery and Development

jun 5, 2019: 3 p.m. - 4 p.m.
104AB, Level 100

Artifical Intelligence (AI) is deeply impacting how biopharma companies operate in drug discovery and development. Deep Learning, the fastest growing segment of AI, enables accurate analytics that were considered too complex just a few years ago. This interactive panel discussion will feature experts to discuss how AI is impacting biopharma R&D in three key areas: drug discovery; clinical development and translational medicine.


Andrew Beck
Co-Founder and CEO

Ron Alfa
Senior Vice President,...

Agam Sheth

Evan Feinberg
Founder and CEO